MTOR and renal cell carcinoma: Elucidation of the roles of vascular endothelial growth factor (VEGF) and mTOR-containing complex 1 (mTORC1) in RCC has led to evaluation of the use of VEGF and mTOR inhibitors for the treatment of RCC.